Bayer Files Lawsuit Against Teva

Anonymous User | Login

Published: 02-Jul-2009

Lawsuit concerns Teva's application for approval to market Levitra for the treatment of erectile dysfunction

Bayer Schering and Bayer HealthCare together with Schering have filed a patent infringement lawsuit in the US Federal Court in the District of Delaware against Teva Pharmaceuticals and Teva Pharmaceutical Industries.

The lawsuit concerns Teva's application to the FDA for approval to market a generic form of Bayer Schering’s therapy, Levitra for the treatment of erectile dysfunction, prior to patent expiration.

The patent at issue in the suit is Bayer Schering Pharma's US Patent No. 6362178 expiring in 2018. In the US, Levitra is marketed by Schering-Plough and GlaxoSmithKline.

Bayer Schering is a specialty pharmaceutical company. It is focused on, Diagnostic Imaging, General Medicine, Specialty Medicine and Women's Healthcare.

No items to display

Network Sites

Contract Research Clinical Trials Contract Services Drug Delivery Drug Discovery & Development OTC Regulatory Affairs Process and Production IT and Software Laboratory Instrumentation Manufacturing Fine & Specialty Chemicals Medical Devices Business Review Inward Investment Packaging

Mail sent successfully

Tell your friend about this article

Please enter a valid email address

Please enter your name

Please enter the mail body

Your Name: *

Your Email: *

Friend's Email: *

Email Body: *: I thought you would be interested in this article : http://regulatoryaffairs.pharmaceutical-business-review.com/news/bayer_files_patent_infringement_lawsuit_against_teva_020709/

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

ADAPT Localization

The Translation and Localization Specialists ...

Adis

Independently Evaluated Drug Information ...

Aris Global

Integrated Software Solutions and Services for Life Sciences ...

Axiom Real Time Metrics

EDC Solutions ...

BioClinica

Global Clinical Trial Solutions. Real-World Results ...

BIOQUELL

Specialist Providers of Bio-decontamination Equipment and Services ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Related Companies

No items to display

Suppliers Product News

BioClinica's Express Platform Receives CDISC Certification

Bio-Imaging Technologies, Inc., (NASDAQ: BITI) d/b/a BioClinica, a leading global provider of clinical trial services, has announced that its Express EDC platform has been certified by the Clinical Data Interchange Standard Consortium (CDISC) as complying with the Operational Data Model (ODM) standard.

Bio-Imaging Technologies, Inc. Shareholders Approve Company's Name Change to BioClinica, Inc.

Bio-Imaging Technologies, Inc. (NASDAQ: BITI), a global provider of clinical trial services, has received shareholder approval to change its name to BioClinica, Inc., effective immediately.

Bioclinica's Jonathan Andrus Named Chair of DIA's eClinicall SIAC

Bio-Imaging Technologies, Inc., (NASDAQ: BITI) d/b/a BioClinica a leading global provider of clinical trial services, announced today that Jonathan Andrus, vice president, clinical data management & regulatory operations at BioClinica's eClinical service division, has been elected as the Drug Information Association (DIA) North American Special Interest Area Communities (SIAC) eClinical Chair.

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750